Invesco Ltd. Has $73,000 Stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Invesco Ltd. lowered its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 97.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,927 shares of the company's stock after selling 670,563 shares during the quarter. Invesco Ltd.'s holdings in Aveanna Healthcare were worth $73,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. KLP Kapitalforvaltning AS purchased a new position in Aveanna Healthcare during the fourth quarter worth $35,000. Catalyst Funds Management Pty Ltd grew its holdings in shares of Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after purchasing an additional 9,000 shares during the period. Arizona State Retirement System purchased a new position in shares of Aveanna Healthcare in the 4th quarter valued at $64,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Aveanna Healthcare in the fourth quarter valued at about $65,000. Finally, EntryPoint Capital LLC acquired a new position in Aveanna Healthcare during the 4th quarter worth approximately $68,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Trading Down 1.5%

AVAH stock traded down $0.08 during midday trading on Friday, hitting $5.42. The stock had a trading volume of 382,964 shares, compared to its average volume of 270,241. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of -15.94 and a beta of 2.01. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.32 and a 52 week high of $6.19. The stock has a 50-day simple moving average of $4.84 and a 200 day simple moving average of $4.89.

Wall Street Analyst Weigh In

AVAH has been the topic of several research analyst reports. UBS Group increased their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday. Truist Financial lowered their target price on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th.

Insider Buying and Selling at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64. Following the completion of the sale, the insider now directly owns 1,453,948 shares of the company's stock, valued at approximately $8,011,253.48. This represents a 4.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In the last 90 days, insiders sold 67,412 shares of company stock worth $372,142. 7.80% of the stock is currently owned by corporate insiders.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.